INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $288,804 | +9.4% | 7,082 | 0.0% | 0.16% | +3.2% |
| Q1 2023 | $263,946 | +0.9% | 7,082 | -5.5% | 0.16% | -18.6% |
| Q4 2022 | $261,501 | -37.6% | 7,495 | 0.0% | 0.19% | -41.7% |
| Q3 2022 | $419,000 | +8.0% | 7,495 | 0.0% | 0.33% | +17.3% |
| Q2 2022 | $388,000 | -28.8% | 7,495 | 0.0% | 0.28% | -18.4% |
| Q1 2022 | $545,000 | -38.5% | 7,495 | 0.0% | 0.35% | -36.6% |
| Q4 2021 | $886,000 | -23.2% | 7,495 | -12.8% | 0.55% | -30.6% |
| Q3 2021 | $1,154,000 | -17.3% | 8,600 | -0.2% | 0.79% | -27.0% |
| Q2 2021 | $1,396,000 | +104.4% | 8,620 | +1.3% | 1.08% | +75.4% |
| Q1 2021 | $683,000 | +47.5% | 8,513 | 0.0% | 0.62% | +47.5% |
| Q4 2020 | $463,000 | – | 8,513 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |